Chronic migraine is a neurological condition defined by experiencing headaches on 15 or more days per month, for more than three months, with at least 8 of those days meeting the criteria for migraine. That distinction from episodic migraine (fewer than 15 headache days per month) matters because chronic migraine carries a heavier burden of disability, higher rates of depression and anxiety, and often requires a different treatment approach.
How Chronic Migraine Differs From Episodic Migraine
Most people think of migraines as occasional, intense attacks. Episodic migraine works that way: you might get a few attacks per month with pain-free stretches in between. Chronic migraine collapses those gaps. When you have headaches more days than not, it becomes harder to distinguish one attack from the next. Some days bring full migraine symptoms (throbbing pain, nausea, light sensitivity), while others feel more like a dull, persistent tension-type headache. Both count toward the 15-day threshold.
Of those 15 or more headache days, at least 8 must have migraine features or respond to migraine-specific medications like triptans. This means chronic migraine isn’t simply “a lot of headaches.” It’s a specific pattern where migraine biology is driving most of the problem, even on days that feel milder.
What Happens in the Brain
Migraine pain originates from nerve fibers that wrap around blood vessels in the protective membranes surrounding the brain. When these pain-sensing nerves activate, they trigger throbbing head pain along with nausea and sensitivity to light and sound. In people with chronic migraine, this system becomes sensitized over time, meaning it fires more easily and resets more slowly.
That sensitization has a noticeable real-world effect: skin sensitivity, known clinically as cutaneous allodynia. Roughly 40 to 70% of people with migraine experience pain from things that shouldn’t hurt, like brushing their hair, resting their head on a pillow, or wearing glasses. In chronic migraine specifically, the rates may climb even higher. This happens because pain signals that start around the blood vessels in the brain gradually “turn up the volume” on nerve pathways throughout the head, neck, and eventually the whole body. The presence of this skin sensitivity is itself associated with a higher risk of migraines becoming chronic.
There’s also a genetic component. People prone to migraine tend to have a cerebral cortex that’s more excitable than average, with an imbalance between the brain’s excitatory and inhibitory signals. This hyperexcitability makes the brain more susceptible to cortical spreading depression, a slow wave of electrical activity that moves across the brain’s surface at 2 to 6 millimeters per minute, followed by a period of suppressed brain activity lasting 15 to 30 minutes. This wave is what causes aura symptoms in some people and may help trigger the pain phase of an attack.
Why Episodic Migraine Becomes Chronic
Chronic migraine rarely starts out chronic. Most people progress from episodic migraine over months or years. The strongest risk factors for this transformation, based on systematic reviews of the evidence, are having a high frequency of headache days to begin with, depression, and overuse of certain acute pain medications.
Medication overuse deserves special attention because it’s both common and fixable. When you use acute headache medications on 10 or more days per month (or 15 or more for simple painkillers) for longer than three months, the medications themselves can start perpetuating headaches. Opioids and combination painkillers containing barbiturates carry the highest risk. This creates a vicious cycle: more headache days lead to more medication use, which leads to even more headache days, which accelerates the slide into chronic migraine. Breaking this cycle often requires gradually reducing acute medication use, sometimes under medical supervision.
These same risk factors appear in children and adolescents, not just adults.
The Link Between Chronic Migraine and Mental Health
The overlap between chronic migraine and psychiatric conditions is striking. Between 30 and 50% of people with chronic migraine also have depression. Anxiety disorders, including generalized anxiety, panic disorder, and PTSD, are at least as common and possibly more so: estimates suggest 50 to 80% of people with chronic migraine experience significant anxiety.
This isn’t coincidental. The relationship runs in both directions. Depression and anxiety increase the risk of migraines becoming chronic, and living with chronic migraine (pain on most days, inability to plan reliably, lost work and social time) fuels depression and anxiety. Treating either condition in isolation tends to produce incomplete results, which is why effective management usually addresses both.
The Daily and Financial Toll
More than 90% of people with migraine report being unable to work or function normally during an attack. When attacks happen on 15 or more days per month, the impact on careers, relationships, and quality of life is severe. Annual direct and indirect costs for someone with chronic migraine run between $8,500 and $9,500 per person, roughly two and a half times higher than the costs for episodic migraine. Over a three-month period, headache-related medical costs alone average about $1,036 for chronic migraine compared to $383 for episodic migraine.
Preventive Treatment Options
Because chronic migraine involves headaches on most days, the treatment strategy shifts from managing individual attacks to reducing the overall number of headache days. This means preventive therapy, taken on a regular schedule regardless of whether you have a headache that day.
Several classes of daily oral medications are used for prevention, including certain blood pressure medications, antidepressants, and anti-seizure drugs. These were originally developed for other conditions but were found to reduce migraine frequency. They typically take several weeks to show full benefit and require patience with dose adjustments.
For people who don’t respond well to oral preventives, injectable treatments targeting a protein called CGRP (a key chemical messenger in migraine pain pathways) have become a major option. These are given monthly or quarterly, either by self-injection at home or as an infusion at a clinic, and tend to have fewer side effects than older oral preventives.
Botulinum toxin injections are specifically approved for chronic migraine and involve 31 or more small injections across the forehead, temples, back of the head, neck, and upper shoulders, totaling 155 units in a standard session with the option to add up to 40 more units in areas where pain is concentrated. Treatments are repeated every 12 weeks. In clinical trials, patients receiving these injections experienced about 8 to 9 fewer headache days per month after six months, compared to about 6 to 7 fewer days with placebo. The most common side effects are neck pain and headache at the injection sites, along with occasional muscle weakness or stiffness in the treated areas.
What Recovery Looks Like
Chronic migraine is manageable, but improvement tends to be gradual rather than dramatic. A realistic early goal is reducing headache days by 50%, which can meaningfully change your ability to work, exercise, and maintain relationships. Some people do revert from chronic back to episodic migraine, especially when modifiable risk factors like medication overuse, untreated depression, or poor sleep are addressed directly.
Treatment often involves trying more than one preventive approach before finding what works, and combining medication with lifestyle adjustments like consistent sleep schedules, regular exercise, and stress management. Tracking your headache days on a calendar or app gives you and your doctor an objective picture of whether things are improving, since it’s surprisingly hard to judge frequency from memory alone.